EIF3H and breast carcinoma: On the other hand, we did not observe a correlation between high EIF3H expression and breast cancer patients’ negative prognosis on the METABRIC dataset, even though both TCGA and METABRIC datasets do not differ on the probability of overall survival for their respective patients’ cohorts (Fig. S2A) nor on other demographic characteristics [39].